PTPN22 and myalgic encephalomeyelitis/chronic fatigue syndrome: We found a significant difference between the ME/CFS patients with an ITO, compared to healthy controls (CTLA4 rs3087243: p = 0.0061, PTPN22 rs2476601: p = 0.026).